JP Stock MarketDetailed Quotes

6425 Universal Entertainment

Watchlist

1036
+12+1.17%

20min DelayMarket Closed Dec 30 15:30 JST

83.08BMarket Cap2.82P/E (Static)

Universal Entertainment Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-34.23%29.46B

-34.98%28.48B

-3.03%34.43B

26.95%179B

4.80%54.9B

38.70%44.79B

53.22%43.8B

28.00%35.5B

55.91%141B

59.94%52.38B

Cost of revenue

-29.41%14.41B

-46.48%11.21B

-11.34%12.85B

27.14%79.66B

13.95%23.81B

32.88%20.41B

46.68%20.95B

19.57%14.5B

42.73%62.66B

53.10%20.89B

Gross profit

-38.26%15.05B

-24.44%17.27B

2.71%21.57B

26.80%99.33B

-1.26%31.09B

43.99%24.38B

59.76%22.86B

34.55%21B

68.34%78.34B

64.83%31.49B

Operating expense

-3.50%17.9B

6.74%18.03B

8.04%17.55B

3.92%68.85B

-14.05%17.18B

7.89%18.54B

6.91%16.89B

22.27%16.24B

48.63%66.26B

55.96%19.99B

Operating profit

-148.67%-2.84B

-112.71%-758M

-15.48%4.02B

152.21%30.48B

20.95%13.92B

2,398.82%5.84B

499.87%5.97B

104.64%4.76B

516.58%12.09B

82.88%11.51B

Net non-operating interest income (expenses)

-67.17%-6.25B

-24.63%-4.35B

-16.48%-4.14B

-7.49%-14.96B

-6.76%-4.17B

-1.47%-3.74B

0.26%-3.49B

-25.97%-3.56B

-33.33%-13.91B

-47.69%-3.91B

Non-operating interest income

-61.13%248M

340.85%313M

367.16%313M

755.47%1.1B

717.95%319M

1,958.06%638M

121.88%71M

157.69%67M

18.52%128M

25.81%39M

Non-operating interest expense

48.46%6.5B

30.94%4.66B

22.97%4.45B

14.31%16.05B

13.78%4.49B

17.80%4.38B

0.85%3.56B

27.18%3.62B

33.18%14.04B

47.44%3.95B

Net investment income

-582.38%-10.13B

-23.95%5.47B

290.53%5.65B

-23.92%6.28B

30.65%-4.45B

-27.61%2.1B

-6.38%7.19B

-64.72%1.45B

46.66%8.26B

-410.19%-6.42B

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-149M

96.58%-4M

Income from associates and other participating interests

338.36%758M

96.25%-274M

-142.91%-230M

-156.83%-6.75B

-47.32%344M

-46.54%-318M

-7,065.69%-7.31B

118.10%536M

-269.70%-2.63B

13.17%653M

Special income (charges)

3,724.14%1.11B

-104.37%-1B

-300.00%-4M

389.63%22.67B

88.71%-227M

101.84%29M

4,970.73%22.87B

-100.01%-1M

134.57%4.63B

64.56%-2.01B

Less:Other special charges

-3,724.14%-1.11B

104.37%1B

300.00%4M

-342.98%-22.72B

-88.04%181M

-101.84%-29M

-4,970.73%-22.87B

100.01%1M

-141.56%-5.13B

-67.24%1.51B

Less:Write off

----

-90.76%46M

----

-52.84%498M

----

Other non-operating income (expenses)

-1,920.00%-182M

-343.59%-95M

1,092.86%278M

985.00%217M

456.36%196M

-95.59%10M

102.09%39M

-101.63%-28M

112.66%20M

-450.00%-55M

Income before tax

-547.02%-17.53B

-103.99%-1.01B

71.69%5.42B

349.09%37.95B

2,414.46%5.6B

250.90%3.92B

2,057.73%25.27B

-68.79%3.16B

156.46%8.45B

-149.29%-242M

Income tax

163.59%2.45B

-73.60%1.92B

830.19%1.97B

411.13%9.51B

111.98%1.1B

-43.27%931M

162.70%7.26B

-87.94%212M

-174.81%-3.06B

-905.15%-9.22B

Net income

-768.20%-19.99B

-116.24%-2.93B

17.11%3.45B

147.17%28.44B

-49.92%4.5B

170.56%2.99B

1,229.61%18.01B

-64.77%2.95B

160.39%11.51B

1,472.63%8.98B

Net income continuous operations

-768.20%-19.99B

-116.24%-2.93B

17.11%3.45B

147.18%28.44B

-49.91%4.5B

170.54%2.99B

1,230.32%18.01B

-64.77%2.95B

160.40%11.51B

1,472.63%8.98B

Noncontrolling interests

Net income attributable to the company

-768.20%-19.99B

-116.24%-2.93B

17.11%3.45B

147.17%28.44B

-49.92%4.5B

170.56%2.99B

1,229.61%18.01B

-64.77%2.95B

160.39%11.51B

1,472.63%8.98B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-768.20%-19.99B

-116.24%-2.93B

17.11%3.45B

147.17%28.44B

-49.92%4.5B

170.56%2.99B

1,229.61%18.01B

-64.77%2.95B

160.39%11.51B

1,472.63%8.98B

Gross dividend payment

Basic earnings per share

-768.01%-257.92

-116.24%-37.75

17.12%44.53

147.16%367.04

-49.92%58.02

170.57%38.61

1,230.30%232.39

-64.77%38.02

160.40%148.5

1,474.26%115.85

Diluted earnings per share

-768.19%-257.92

-116.25%-37.75

17.12%44.53

147.15%367

-49.92%58.02

170.55%38.6

1,230.11%232.35

-64.77%38.02

160.39%148.49

1,472.56%115.85

Dividend per share

-25.00%30

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-34.23%29.46B	-34.98%28.48B	-3.03%34.43B	26.95%179B	4.80%54.9B	38.70%44.79B	53.22%43.8B	28.00%35.5B	55.91%141B	59.94%52.38B
Cost of revenue	-29.41%14.41B	-46.48%11.21B	-11.34%12.85B	27.14%79.66B	13.95%23.81B	32.88%20.41B	46.68%20.95B	19.57%14.5B	42.73%62.66B	53.10%20.89B
Gross profit	-38.26%15.05B	-24.44%17.27B	2.71%21.57B	26.80%99.33B	-1.26%31.09B	43.99%24.38B	59.76%22.86B	34.55%21B	68.34%78.34B	64.83%31.49B
Operating expense	-3.50%17.9B	6.74%18.03B	8.04%17.55B	3.92%68.85B	-14.05%17.18B	7.89%18.54B	6.91%16.89B	22.27%16.24B	48.63%66.26B	55.96%19.99B
Operating profit	-148.67%-2.84B	-112.71%-758M	-15.48%4.02B	152.21%30.48B	20.95%13.92B	2,398.82%5.84B	499.87%5.97B	104.64%4.76B	516.58%12.09B	82.88%11.51B
Net non-operating interest income (expenses)	-67.17%-6.25B	-24.63%-4.35B	-16.48%-4.14B	-7.49%-14.96B	-6.76%-4.17B	-1.47%-3.74B	0.26%-3.49B	-25.97%-3.56B	-33.33%-13.91B	-47.69%-3.91B
Non-operating interest income	-61.13%248M	340.85%313M	367.16%313M	755.47%1.1B	717.95%319M	1,958.06%638M	121.88%71M	157.69%67M	18.52%128M	25.81%39M
Non-operating interest expense	48.46%6.5B	30.94%4.66B	22.97%4.45B	14.31%16.05B	13.78%4.49B	17.80%4.38B	0.85%3.56B	27.18%3.62B	33.18%14.04B	47.44%3.95B
Net investment income	-582.38%-10.13B	-23.95%5.47B	290.53%5.65B	-23.92%6.28B	30.65%-4.45B	-27.61%2.1B	-6.38%7.19B	-64.72%1.45B	46.66%8.26B	-410.19%-6.42B
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	0	0	-149M	0			0	0	96.58%-4M
Income from associates and other participating interests	338.36%758M	96.25%-274M	-142.91%-230M	-156.83%-6.75B	-47.32%344M	-46.54%-318M	-7,065.69%-7.31B	118.10%536M	-269.70%-2.63B	13.17%653M
Special income (charges)	3,724.14%1.11B	-104.37%-1B	-300.00%-4M	389.63%22.67B	88.71%-227M	101.84%29M	4,970.73%22.87B	-100.01%-1M	134.57%4.63B	64.56%-2.01B
Less:Other special charges	-3,724.14%-1.11B	104.37%1B	300.00%4M	-342.98%-22.72B	-88.04%181M	-101.84%-29M	-4,970.73%-22.87B	100.01%1M	-141.56%-5.13B	-67.24%1.51B
Less:Write off	----	----	----	-90.76%46M	----	----	----	----	-52.84%498M	----
Other non-operating income (expenses)	-1,920.00%-182M	-343.59%-95M	1,092.86%278M	985.00%217M	456.36%196M	-95.59%10M	102.09%39M	-101.63%-28M	112.66%20M	-450.00%-55M
Income before tax	-547.02%-17.53B	-103.99%-1.01B	71.69%5.42B	349.09%37.95B	2,414.46%5.6B	250.90%3.92B	2,057.73%25.27B	-68.79%3.16B	156.46%8.45B	-149.29%-242M
Income tax	163.59%2.45B	-73.60%1.92B	830.19%1.97B	411.13%9.51B	111.98%1.1B	-43.27%931M	162.70%7.26B	-87.94%212M	-174.81%-3.06B	-905.15%-9.22B
Net income	-768.20%-19.99B	-116.24%-2.93B	17.11%3.45B	147.17%28.44B	-49.92%4.5B	170.56%2.99B	1,229.61%18.01B	-64.77%2.95B	160.39%11.51B	1,472.63%8.98B
Net income continuous operations	-768.20%-19.99B	-116.24%-2.93B	17.11%3.45B	147.18%28.44B	-49.91%4.5B	170.54%2.99B	1,230.32%18.01B	-64.77%2.95B	160.40%11.51B	1,472.63%8.98B
Noncontrolling interests		0	0				0	0
Net income attributable to the company	-768.20%-19.99B	-116.24%-2.93B	17.11%3.45B	147.17%28.44B	-49.92%4.5B	170.56%2.99B	1,229.61%18.01B	-64.77%2.95B	160.39%11.51B	1,472.63%8.98B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-768.20%-19.99B	-116.24%-2.93B	17.11%3.45B	147.17%28.44B	-49.92%4.5B	170.56%2.99B	1,229.61%18.01B	-64.77%2.95B	160.39%11.51B	1,472.63%8.98B
Gross dividend payment
Basic earnings per share	-768.01%-257.92	-116.24%-37.75	17.12%44.53	147.16%367.04	-49.92%58.02	170.57%38.61	1,230.30%232.39	-64.77%38.02	160.40%148.5	1,474.26%115.85
Diluted earnings per share	-768.19%-257.92	-116.25%-37.75	17.12%44.53	147.15%367	-49.92%58.02	170.55%38.6	1,230.11%232.35	-64.77%38.02	160.39%148.49	1,472.56%115.85
Dividend per share	0	-25.00%30	0	40	0	0	40	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.